4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Xiaoyan Qu, Lijuan Chen, Tian Tian, Limin Duan, Ruinan Lu, Hua Lu, Hanxin Wu, Jianyong Li. Clinical features of multiple myeloma patients with isolated extramedullary relapse[J]. The Journal of Biomedical Research, 2018, 32(4): 264-269. DOI: 10.7555/JBR.31.20140090
Citation: Xiaoyan Qu, Lijuan Chen, Tian Tian, Limin Duan, Ruinan Lu, Hua Lu, Hanxin Wu, Jianyong Li. Clinical features of multiple myeloma patients with isolated extramedullary relapse[J]. The Journal of Biomedical Research, 2018, 32(4): 264-269. DOI: 10.7555/JBR.31.20140090

Clinical features of multiple myeloma patients with isolated extramedullary relapse

Funds: 

This work was supported by Foundation of National Natural Science Foundation of China (81241074,81071946 and 81302040), Natural Science Foundation of Jiangsu Province (BK2012485), Jiangsu Province's Medical Elite Program (RC201148)

a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU, Clinical Research Program from Health Ministry of China (Key project 2010 to 2012), and Scientific Research Program for Public Interests from the Health Ministry of China (No. 201202017)

More Information
  • Received Date: July 08, 2014
  • Revised Date: October 15, 2014
  • This study sought to analyze the clinical features and prognosis of multiple myeloma with isolated extramedullary relapse and with the absence of systemic progression. The clinical features and outcome were retrospectively analyzed in six multiple myeloma patients. These patients had secretory multiple myeloma at diagnosis. When relapsed, the dissociation between medullary and extramedullary response was detected. The serum or urine monoclonal component was extremely low or absent. The plasma cells in bone marrow were < 5%. All patients received new targeted therapies (thalidomide or bortezomib) before extramedullary relapse. It is difficult to achieve second remission for them. Even in those showing response, the duration of response was extremely short. The median of overall survival from diagnosis and from extramedullary relapse was 19 months and 6 months, respectively. The overall survival was significantly shorter compared to the patients without extramedullary involvement (84 months, P = 0.001). These patients exhibited a special and rare relapse pattern. Patients with this relapse pattern were resistant to current therapies, including novel targeted agents and associated with poor prognosis.
  • Related Articles

    [1]Jiaqi Tang, Lin Luo, Bakwatanisa Bosco, Ning Li, Bin Huang, Rongrong Wu, Zihan Lin, Ming Hong, Wenjie Liu, Lingxiang Wu, Wei Wu, Mengyan Zhu, Quanzhong Liu, Peng Xia, Miao Yu, Diru Yao, Sali Lv, Ruohan Zhang, Wentao Liu, Qianghu Wang, Kening Li. Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis[J]. The Journal of Biomedical Research, 2024, 38(4): 397-412. DOI: 10.7555/JBR.38.20240065
    [2]Yingzhou Tu, Sen Wang, Haoran Wang, Peiyao Zhang, Mengyu Wang, Cunming Liu, Chun Yang, Riyue Jiang. The role of perioperative factors in the prognosis of cancer patients: A coin has two sides[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240164
    [3]Jia Xinyu, Zhang Hengrui, Ma Yuan, Wu Zhenzhen, Ji Ningfei, Huang Mao. The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients[J]. The Journal of Biomedical Research, 2021, 35(3): 247-252. DOI: 10.7555/JBR.34.20200079
    [4]Chen Fei, Li Yuancheng, Qin Na, Wang Fengliang, Du Jiangbo, Wang Cheng, Du Fangzhi, Jiang Tao, Jiang Yue, Dai Juncheng, Hu Zhibin, Lu Cheng, Shen Hongbing. RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer[J]. The Journal of Biomedical Research, 2020, 34(2): 129-138. DOI: 10.7555/JBR.34.20190111
    [5]Yong Ji, Mingfeng Zheng, Shugao Ye, Jingyu Chen, Yijiang Chen. PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer[J]. The Journal of Biomedical Research, 2014, 28(6): 462-467. DOI: 10.7555/JBR.27.20130084
    [6]Jiadai Xu, Tingmei Chen, Yun Liu, Huayuan Zhu, Wei Wu, WenYi Shen, Bei Xu, Sixuan Qian, Jianyong Li, Peng Liu. Easily manageable prognostic factors in 152 Chinese elderly acute myeloid leukemia patients: a single-center retrospective study[J]. The Journal of Biomedical Research, 2014, 28(5): 396-405. DOI: 10.7555/JBR.28.20130164
    [7]Yun Pan, Chongqi Sun, Mingde Huang, Yao Liu, Fuzhen Qi, Li Liu, Juan Wen, Jibin Liu, Kaipeng Xie, Hongxia Ma, Zhibin Hu, Hongbing Shen. A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2014, 28(3): 194-200. DOI: 10.7555/JBR.28.20140052
    [8]Ritu MGilhotra, Mohd Ikram, Sunny Srivastava, Neeraj Gilhotra. A clinical perspective on mucoadhesive buccal drug delivery systems[J]. The Journal of Biomedical Research, 2014, 28(2): 81-97. DOI: 10.7555/JBR.27.20120136
    [9]Zhaoming Wang, Qiaoyu Liu, Hai Wang. Medical simulation-based education improves medicos' clinical skills[J]. The Journal of Biomedical Research, 2013, 27(2): 81-84. DOI: 10.7555/JBR.27.20120131
    [10]Xin Gao, Jintao Zhang, Ying Peng, Huanqing Fan, Mei Chen, Tan Xu, Yonghong Zhang. Admission clinical characteristics and early clinical outcomes among acute ischemic stroke patients[J]. The Journal of Biomedical Research, 2012, 26(3): 152-158. DOI: 10.7555/JBR.26.20110129

Catalog

    Article Metrics

    Article views (3519) PDF downloads (126) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return